Curaleaf International Medical Cannabis
Provider 
Founded 2014
Sells To Consumers
Pricing Model Transactional
Ownership Public

Curaleaf acquired Four 20 Pharma, a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis.
Curaleaf acquired Four 20 Pharma, a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis.
The company is a direct competitor in the German market per Research and Markets report, supplying cannabis-based prescription medicines.
| Attribute | Curaleaf International Medical Cannabis | Cannabis-Based Prescription Medicines | |
|---|---|---|---|
| Provider | |||
| Founded | 2014 | 2019 | |
| Sells To | Consumers | — | |
| Pricing Model | Transactional | — | |
| Ownership | Public | — |
Provider 
Founded 2014
Sells To Consumers
Pricing Model Transactional
Ownership Public
Provider 
Founded 2019
Sells To —
Pricing Model —
Ownership —


Tilray is a leading global medical cannabis company active in Germany supplying cannabis flowers and extracts.
Cannamedical is a German medical cannabis company focused on supply and distribution.


Canopy Growth operates in Germany via Canopy Growth Germany GmbH, supplying cannabis flowers and extracts.


Aurora operates in Germany via Aurora Deutschland GmbH, supplying cannabis flowers and extracts.
DEMECAN is a German medical cannabis producer and distributor.
Tilray is a leading global medical cannabis company active in Germany supplying cannabis flowers and extracts.

Cannamedical is a German medical cannabis company focused on supply and distribution.
Canopy Growth operates in Germany via Canopy Growth Germany GmbH, supplying cannabis flowers and extracts.

Aurora operates in Germany via Aurora Deutschland GmbH, supplying cannabis flowers and extracts.

DEMECAN is a German medical cannabis producer and distributor.